Open AccessP120: TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE‐BLIND, PLACEBO‐CONTROLLED PHASE 2A CROSSWALK‐C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO‐OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)
Author(s) -
Callaghan M,
Ataga K,
De Franceschi L,
Minniti C,
Balachandran N,
Imbs D,
Perretti T,
Ramos J,
Sostelly A,
Bartolucci P
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000821572.78026.e4
Subject(s) - medicine , eculizumab , paroxysmal nocturnal hemoglobinuria , complement system , alternative complement pathway , immunology , acute chest syndrome , placebo , gastroenterology , sickle cell anemia , immune system , pathology , disease , alternative medicine